生物制造
毕赤酵母
生物净化
化学
代谢工程
生物化学
合成生物学
生物过程
甲醇
生物合成
生物反应器
生物技术
酪氨酸
生物催化
生化工程
代谢途径
组合化学
商品化学品
毕赤酵母
有机化学
作者
Chunting Ye,Bowen Ke,Pengcheng Ren,Liu Yang,S Q Wang,Rui Shi,Qingzhu Wang,Faying Zhang,Shuangyan Han
标识
DOI:10.1021/acssuschemeng.5c12347
摘要
The transition from sugar-based biorefining to C1-based biomanufacturing represents a pivotal step toward sustainable chemical production. In this study, we report the design and construction of a novel Pichia pastoris cell factory for the de novo biosynthesis of p -coumaric acid ( p -CA), a valuable pharmaceutical precursor, using methanol as the carbon source. To overcome the inherent challenges of methanol and product toxicity, an engineered P. pastoris S12 strain with enhanced phospholipid biosynthesis was employed as the chassis, conferring superior tolerance to both methanol and p -CA. By integration of dual biosynthetic pathways originating from tyrosine and phenylalanine, a titer of 1.83 g/L was achieved. Systematic metabolic engineering, which includes the deregulation of feedback inhibition in the shikimate pathway, the enhancement of aromatic amino acid precursor supply, and improved methanol utilization, collectively increased p -CA production to 2.80 g/L in flask cultures. Remarkably, scale-up in a 7 L bioreactor yielded a final titer of 15.58 g/L, which is the highest level reported to date for p -CA production from any C1 feedstock. This work not only establishes a scalable and sustainable route for p -CA synthesis but also provides a strategic blueprint for advancing the C1-based biomanufacturing of complex plant secondary metabolites.
科研通智能强力驱动
Strongly Powered by AbleSci AI